Detalhe da pesquisa
1.
Evaluating Vaccination Programs That Prevent Diseases With Potentially Catastrophic Health Outcomes: How Can We Capture the Value of Risk Reduction?
Value Health
; 24(1): 86-90, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33431158
2.
Relationship between financial impact and coverage of drugs in Australia.
Int J Technol Assess Health Care
; 29(1): 92-100, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23217275
3.
The Impact of Social Determinants of Health on Meningococcal Vaccination Awareness, Delivery, and Coverage in Adolescents and Young Adults in the United States: A Systematic Review.
Vaccines (Basel)
; 11(2)2023 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36851134
4.
Use of Cost-Effectiveness Analyses for Decisions About Vaccination Programs for Meningococcal Disease in the United States, United Kingdom, The Netherlands, and Canada.
Expert Rev Vaccines
; 20(1): 59-72, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33455487
5.
Intra-articular Hyaluronic Acid for Osteoarthritis of the Knee in the United States: A Systematic Review of Economic Evaluations.
Clin Med Insights Arthritis Musculoskelet Disord
; 14: 11795441211047284, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34840501
6.
Factors affecting the health-related quality of life of patients with cervical dystonia and impact of treatment with abobotulinumtoxinA (Dysport): results from a randomised, double-blind, placebo-controlled study.
BMJ Open
; 4(10): e005150, 2014 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-25324317